ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Immunosuppression"

  • 2016 American Transplant Congress

    Contrasting Effects of Tacrolimus and Everolimus on Regulatory T Cell Activation and Mixed Hematopoietic Chimerism Induced by Natural Killer T Cell Stimulation.

    S. Miyairi,1,2 T. Hirai,1 R. IShii,1 M. Okumi,1 Y. Ishii,3 S. Nunoda,2 K. Yamazaki,2 K. Tanabe.1

    1Urology, Tokyo Women's Medical University, Tokyo, Japan; 2Cardiovascular Surgery, Tokyo Women's Medical University, Tokyo, Japan; 3Laboratory of Vaccine Design, RIKEN IMS-RCAI, Yokohama, Japan.

    Calcineurin (CN)-dependent IL-2 production is crucial for regulatory T cells (Tregs) to demonstrate suppressive activity. The mTOR signal is not required for Treg function because…
  • 2016 American Transplant Congress

    Pre-Transplant Risk Factors: Predicting Nonadherence and Rejection in Adult Liver Transplant Recipients.

    S. Lieber,1 J. Helcer,1 E. Leven,1 C. Knight,2 C. Wlodarkiewicz,2 A. Shenoy,1 E. Shemesh,1 S. Florman,3 T. Schiano,3 R. Annunziato.1

    1Icahn School of Medicine Mount Sinai Hospital, NY; 2Fordham University, NY; 3Recanati/Miller Transplant Institute Mount Sinai Hospital, NY.

    Purpose: The pre-liver transplant (LT) psychosocial evaluation aims to identify risk factors for immunosuppression nonadherence (NA) and poor post-LT outcomes. Despite broad support for these…
  • 2016 American Transplant Congress

    Therapeutically Equivalent Results to Caucasians in Black Kidney Transplant Recipients Using ASTAGRAF XL® Despite a Higher Degree of HLA Mismatch : A Post-Hoc Analysis of Phase III Data from Over 2000 Patients.

    J. Schwartz, S. Wilson, F. Shi, N. Undre, M. Kumar.

    Astelleas Pharma Global Develepment, Northbrook, IL.

    INTRO: When contemplating the use of a new immunosuppressant agent in kidney transplantation, measuring outcomes in potentially vulnerable populations is of paramount concern. As such,…
  • 2016 American Transplant Congress

    Does Post-Transplant Adherence Come at a Cost?

    K. Yadav, T. Nevins, D. Vock, W. Thomas, W. Robiner, A. Matas.

    University of Minnesota, Minneapolis, MN.

    Background: It is well documented that organ transplant (tx)recipients have an increased incidence of cancer including virus associated cancers like lymphoma. Our objective was to…
  • 2016 American Transplant Congress

    Mycophenolic Acid Product Discontinuation Prior to Conception: Analysis of Pregnancies in Kidney Transplant Recipients.

    S. Constantinescu,1,2 L. Coscia,2 D. Armenti,2 M. Moritz.2,3

    1Medicine, Temple University, Philadelphia, PA; 2Gift of Life Institute, National Transplantation Pregnancy Registry (NTPR), Philadelphia, PA; 3Surgery, Lehigh Valley Health Network, Allentown, PA.

    Mycophenolic acid (MPA) products are considered teratogenic and transplant centers report discontinuing MPA in female kidney recipients anticipating pregnancy. Data were collected by the National…
  • 2016 American Transplant Congress

    Avoidance of CNI and Steroids Using Belatacept – A Preliminary Report of CTOT-16.

    R. Mannon,1 P. Stock,2 A. Mehta,3 D. Ikle,4 N. Watson,5 N. Bridges,5 M. Robien,5 K. Newell.3

    1UAB, Birmingham; 2UCSF, San Francisco; 3Emory, Atlanta; 4Rho, Chapel Hill; 5NIAID, Bethesda.

    CTOT-16 tested the hypothesis that belatacept used as maintenance immunosuppression (IS) in kidney transplantation would allow the long-term avoidance of CNI and corticosteroids. Methods: Primary…
  • 2016 American Transplant Congress

    Ibrutinib Suppresses Alloantibody Responses in A Mouse Model of Allosensitization: A Preliminary Report.

    G. Wu, I. Kim, N.-N. Chai, A. Klein, S. Jordan.

    CTC/Surgery, Cedars-Sinai Medical Center, Los Angeles, CA.

    Background Ibrutinib is a Bruton tyrosine Kinase (BTK) antagonist that inhibits B cell receptor (BCR) signaling, therefore blocking B cell activation. Ibrutinib is approved by…
  • 2016 American Transplant Congress

    Refill-Based Immunosuppression Non-Adherence Is Associated with Increased Death Censored Graft Loss.

    K. Wen, S. Gourishankar, S. Shojai, A. Wong, M. Bae, D. Grynoch, P. Halloran.

    Medicine, University of Alberta, Edmonton, AB, Canada.

    Introduction Medication non-adherence is a major contributor of graft loss in kidney transplant(KTX) recipients. We aim to evaluate the association of immunosuppression non-adherence to graft…
  • 2016 American Transplant Congress

    A Comprehensive Biomarker Study to Compare Tacrolimus and Mycophenolic Acid versus Half-Dose Tacrolimus and Everolimus in De Novo Kidney Transplant Patients in the Novartis US92 Study.

    J. Klepacki,1 J. Klawitter,1 J. Klawitter,1 A. Karimpour-fard,2 E. Anderson,1 G. Ingle,3 D. Patel,3 K. Johnson,4 D. Cibrik,4 U. Christians.1

    1University of Colorado Denver, Aurora, CO; 2University of Colorado Denver, Aurora, CO; 3Novartis Pharmaceuticals, East Hannover, NJ; 4University of Michigan, Ann Arbor, MI.

    In this exploratory biomarker sub-study, a comprehensive combined targeted/ non-targeted metabolomics and targeted proteomics approach was used to assess potential differences between the everolimus+ low-dose…
  • 2016 American Transplant Congress

    Predicting Emergence of Anti-HLA Class I and II Antibodies by Time Dependent Phenomapping in Heart Transplant Patients.

    M. Bakir, N. Jackson, E. Chang, D. Henriquez-Ticas, C.-H. Tseng, T. Khuu, J. Zhang, E. Reed, M. Deng, M. Cadeiras.

    Cardiology, University of California-Los Angeles, Los Angeles, CA.

    Purpose: The presence of circulating HLA antibodies which is termed allosensitization among heart transplant (HTx) candidates are associated with poorer posttransplant outcomes including increased morbidity…
  • « Previous Page
  • 1
  • …
  • 108
  • 109
  • 110
  • 111
  • 112
  • …
  • 138
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences